|
DFB Pharmaceuticals, Inc. is a privately held U.S.-based corporation, with a history dating back to the 1930s in San Antonio, Texas. Under the current ownership, in place since 1990, DFB Pharmaceuticals has developed a broad-based portfolio of operating businesses.
Acquired from Alcon in 1990, DPT Laboratories is a contract development and manufacturing company with vast experience in liquid and semi-solid manufacturing and topical product development.
Healthpoint, launched in 1992, markets and distributes biologic, pharmaceutical and novel medical products through its Tissue Management and Infect Prevention divisions.
In 2003, DFB acquired Phyton Inc. to pursue the discovery, development and commercialization of high-value chemical compounds, leveraging Phyton's proprietary plant cell fermentation technology.
Today, DFB's strategy is to develop and acquire new products and technologies for U.S. and Canadian markets, as well as expand via out-licensing proprietary brands and technologies through partners worldwide.
|
